S040 Hot Topics in Pediatric Dermatology
DESCRIPTION
This symposium aims to give up to date, in depth information regarding new and emerging trends in pediatric dermatology. The session will cover what is new in the management of inflammatory skin diseases in children such as acne, atopic dermatitis and psoriasis. It will also delve into recent innovations in the care of patients with epidermolysis and epidermal differentiation disorders (ichthyoses). Other hot topics addressed will include management of infectious diseases, rheumatologic/dermtologic conditions in children and adolescents, as well as highlighting recent pediatric dermatology literature that is relevant to clinical care.
LEARNING OBJECTIVES
Analyze and discuss emerging trends impacting the care of children with inflammatory diseases with respect to diagnosis and treatment
Formulate approaches to management of select genetic disease with evolving therapeutic options
Recognize changing presentations, pathophysiologic insights and management of infections and reactive mucosal eruptions including RIME and SCARs (severe cutaneous adverse reactions)
SCHEDULE
1:00 PM
Introduction
Lawrence F Eichenfield, MD, FAAD
1:03 PM
Pediatric Psoriasis Update
Kelly M. Cordoro, MD, FAAD
1:21 PM
Infectious Diseases
Mary Elizabeth Larijani, MD, FAAD
1:39 PM
SJS/RIME/Severe Cutaneous Adverse Drug Eruptions
Reid Oldenburg, MD, PhD, FAAD
1:58 PM
Atopic Dermatitis Update
Dawn Eichenfield, PhD, MD, FAAD
2:16 PM
Panel Q and A
Kelly M. Cordoro, MD, FAAD, Dawn Eichenfield, PhD, MD, FAAD, Mary Elizabeth Larijani, MD, FAAD, Reid Oldenburg, MD, PhD, FAAD
2:30 PM
Epidermolysis Bullosa and EDD (Ichthyoses) Update
Amy S. Paller, MD, FAAD
2:48 PM
Pediatric Acne and Rosacea
Dawn Eichenfield, PhD, MD, FAAD
3:06 PM
Pediatric Derm/Rheum Update
Heather Gochnauer, MD, FAAD
3:24 PM
Hot Articles from the journal Pediatric Dermatology
Lionel Gordon Bercovitch, MD, FAAD, Andrea L. Zaenglein, MD, FAAD
3:44 PM
Panel Q and A
Lawrence F Eichenfield, MD, FAAD, Lionel Gordon Bercovitch, MD, FAAD, Dawn Eichenfield, PhD, MD, FAAD, Amy S. Paller, MD, FAAD, Andrea L. Zaenglein, MD, FAAD
DIRECTOR
Lawrence F Eichenfield, MD, FAAD
SPEAKERS
Lionel Gordon Bercovitch, MD, FAAD
Kelly M. Cordoro, MD, FAAD
Dawn Eichenfield, PhD, MD, FAAD
Heather Gochnauer, MD, FAAD
Mary Elizabeth Larijani, MD, FAAD
Reid Oldenburg, MD, PhD, FAAD
Amy S. Paller, MD, FAAD
Andrea L. Zaenglein, MD, FAAD
DISCLOSURES
Lionel Gordon Bercovitch, MD, FAAD
No financial relationships exist with ineligible companies.
Kelly M. Cordoro, MD, FAAD
No financial relationships exist with ineligible companies.
Dawn Eichenfield, PhD, MD, FAAD
Amryt Pharma/ Chiesi Farmaceutici – Consultant(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, LP – Speaker(Honoraria); Incyte Corporation – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); NobelPharma – Advisory Board(Fees), Speaker(Honoraria); Ortho Dermatologics – Advisory Board(Fees); Palvella Therapeutics – Consultant (1099 relationship)(Fees); Pelthos Therapeutics – Advisory Board(Fees); Sanofi/Regeneron – Speaker(Honoraria); Verrica Pharmaceuticals Inc – Advisory Board(Fees), Speaker(Honoraria);
Lawrence F Eichenfield, MD, FAAD
AbbVie – Consultant(Honoraria); Abbvie – Investigator(Grants/Research Funding); Abeona Therapeutics – Consultant (1099 relationship)(Honoraria); Acrotech Biopharma Inc – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Amryt Pharma – Consultant(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Board of Directors(Fees), Board of Directors(Stock Options); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); Kymera Therapeutics – Consultant (1099 relationship)(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);
Heather Gochnauer, MD, FAAD
No financial relationships exist with ineligible companies.
Mary Elizabeth Larijani, MD, FAAD
No financial relationships exist with ineligible companies.
Reid Oldenburg, MD, PhD, FAAD
Blueprint Medicines – Advisory Board(Fees); Novartis – Advisory Board(Fees);
Amy S. Paller, MD, FAAD
AbbVie – Data Safety Monitoring Board(Honoraria), Investigator(Grants/Research Funding); Abeona Therapeutics – Data Safety Monitoring Board(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); BioCryst Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); BioMendics, LLC – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria); Castle Creek Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Daiichi Sankyo – Data Safety Monitoring Board(Honoraria); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Galderma – Data Safety Monitoring Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Krystal Biotech, Inc – Consultant(Honoraria); L'Oréal France – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); Pelthos Therapeutics – Consultant (1099 relationship)(Honoraria); Quoin Pharmaceuticals Ltd – Consultant (1099 relationship)(Honoraria); Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi Genzyme – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Andrea L. Zaenglein, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Biofrontera AG – Investigator(Grants/Research Funding); Church & Dwight Co., Inc. – Consultant(Fees); Dermavant Sciences, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);